500,000-Patient study aims to unlock secrets of chronic liver disease

NCT ID NCT05744713

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Target PharmaSolutions, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study will follow up to 500,000 adults with chronic liver disease or cirrhosis to understand how the disease progresses and how treatments are used in everyday practice. Researchers will collect data from medical records and patient reports to improve care and outcomes. No new treatments are being tested; instead, the goal is to gather real-world evidence to guide future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could provide valuable insights into how chronic liver disease progresses and how current treatments work in real-world settings.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test new therapies. Results may take years and might not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC LIVER DISEASE CIRRHOSIS

Contacts and locations

Locations

Atrium Health Center for Liver Disease and Transplant

Charlotte, North Carolina, 28204, United States
Baylor College of Medicine

Houston, Texas, 77021, United States
Baylor Scott & White Research Institute

Dallas, Texas, 75246, United States
Columbia University Irving Medical Center/ New York Presbyterian Hospital

New York, New York, 10032, United States
Georgetown Medstar Transplant Institute

Washington D.C., District of Columbia, 20007, United States
Keck School of Medicine of USC

Los Angeles, California, 90033, United States
Rush University Medical Center

Chicago, Illinois, 60612, United States
Stanford Medicine

Redwood City, California, 94063, United States
Temple University - Lewis Katz School of Medicine

Philadelphia, Pennsylvania, 19140, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.